Sickle cell retinopathy: What we now understand using optical coherence tomography angiography. A systematic review
For over four decades, efforts have been underway for the evaluation of sickle cell retinopathy (SCR) in an attempt to identify peripheral high-risk vascular abnormalities based on Goldberg's classification (gold-standard) (1971). The macula is an area in the center of the retina that is respon...
Gespeichert in:
Veröffentlicht in: | Blood reviews 2019-05, Vol.35, p.32-42 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 42 |
---|---|
container_issue | |
container_start_page | 32 |
container_title | Blood reviews |
container_volume | 35 |
creator | Leitão Guerra, Ricardo Luz Leitão Guerra, Cezar Luz Bastos, Mariana Gouveia de Oliveira, André Hasler Príncipe Salles, Cristina |
description | For over four decades, efforts have been underway for the evaluation of sickle cell retinopathy (SCR) in an attempt to identify peripheral high-risk vascular abnormalities based on Goldberg's classification (gold-standard) (1971). The macula is an area in the center of the retina that is responsible for high-resolution central vision and is also affected in SCR. With the development of new technologies for retinal imaging, the macula became a main focus of interest in the study of sickle cell disease (SCD). Optical coherence tomography angiography is a modern non-invasive method that allows qualitative and quantitative analysis of the retinal vascular network in the macular region. We identified 86 studies on SCD and optical coherence tomography angiography. Of those, 12 met the inclusion criteria for this systematic review. The prevalence of sickle cell maculopathy was 45.6% in the SCD population and it increased with age. We present the main vascular findings and discuss visual impairment and pathophysiology, genotypes, and peripheral high-risk vascular abnormalities. The role of the hematologist, general practitioner, and pediatrician in treatment is also reviewed. |
doi_str_mv | 10.1016/j.blre.2019.03.001 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2190120671</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0268960X1830119X</els_id><sourcerecordid>2190120671</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-661d526193a2f815f23c7e068ec25c6f724ec05bd0814c7f22bac8f2aa905c783</originalsourceid><addsrcrecordid>eNp9kE1P3DAURa2KCqbAH-gCeckm6bONnaRig0b9kpC6gKrsLI_zMuMhiYPtMJp_30QzZcnKb3Hute4h5DODnAFTX7b5qg2Yc2BVDiIHYB_IgknBM6ZKdkIWwFWZVQqezsinGLcAUAlVnJIzAaXkIIsFiQ_OPrdILbYtDZhc7weTNvuv9O_GJLpD2vsdHfsaQ0ymr-kYXb-mfkjOmpZav8GAvUWafOfXwQybPTX92h3vnN7RuI8JOzMFpg9eHe4uyMfGtBEvj-85-fP92-PyZ3b_-8ev5d19ZoVUKVOK1ZIrVgnDm5LJhgtbIKgSLZdWNQW_QQtyVUPJbmzRcL4ytmy4MRVIW5TinFwfeofgX0aMSXcuzkNNj36MmrMKGAdVsAnlB9QGH2PARg_BdSbsNQM9y9ZbPcvWs2wNQk-yp9DVsX9cdVi_Rf7bnYDbA4DTyml50NG62VbtAtqka-_e6_8HbbeSLw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2190120671</pqid></control><display><type>article</type><title>Sickle cell retinopathy: What we now understand using optical coherence tomography angiography. A systematic review</title><source>Access via ScienceDirect (Elsevier)</source><creator>Leitão Guerra, Ricardo Luz ; Leitão Guerra, Cezar Luz ; Bastos, Mariana Gouveia ; de Oliveira, André Hasler Príncipe ; Salles, Cristina</creator><creatorcontrib>Leitão Guerra, Ricardo Luz ; Leitão Guerra, Cezar Luz ; Bastos, Mariana Gouveia ; de Oliveira, André Hasler Príncipe ; Salles, Cristina</creatorcontrib><description>For over four decades, efforts have been underway for the evaluation of sickle cell retinopathy (SCR) in an attempt to identify peripheral high-risk vascular abnormalities based on Goldberg's classification (gold-standard) (1971). The macula is an area in the center of the retina that is responsible for high-resolution central vision and is also affected in SCR. With the development of new technologies for retinal imaging, the macula became a main focus of interest in the study of sickle cell disease (SCD). Optical coherence tomography angiography is a modern non-invasive method that allows qualitative and quantitative analysis of the retinal vascular network in the macular region. We identified 86 studies on SCD and optical coherence tomography angiography. Of those, 12 met the inclusion criteria for this systematic review. The prevalence of sickle cell maculopathy was 45.6% in the SCD population and it increased with age. We present the main vascular findings and discuss visual impairment and pathophysiology, genotypes, and peripheral high-risk vascular abnormalities. The role of the hematologist, general practitioner, and pediatrician in treatment is also reviewed.</description><identifier>ISSN: 0268-960X</identifier><identifier>EISSN: 1532-1681</identifier><identifier>DOI: 10.1016/j.blre.2019.03.001</identifier><identifier>PMID: 30852057</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>OCT angiography ; Optical coherence tomography angiography ; Sickle cell anemia ; Sickle cell disease ; Sickle cell maculopathy ; Sickle cell retinopathy</subject><ispartof>Blood reviews, 2019-05, Vol.35, p.32-42</ispartof><rights>2019 Elsevier Ltd</rights><rights>Copyright © 2019 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-661d526193a2f815f23c7e068ec25c6f724ec05bd0814c7f22bac8f2aa905c783</citedby><cites>FETCH-LOGICAL-c356t-661d526193a2f815f23c7e068ec25c6f724ec05bd0814c7f22bac8f2aa905c783</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.blre.2019.03.001$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27929,27930,46000</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30852057$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Leitão Guerra, Ricardo Luz</creatorcontrib><creatorcontrib>Leitão Guerra, Cezar Luz</creatorcontrib><creatorcontrib>Bastos, Mariana Gouveia</creatorcontrib><creatorcontrib>de Oliveira, André Hasler Príncipe</creatorcontrib><creatorcontrib>Salles, Cristina</creatorcontrib><title>Sickle cell retinopathy: What we now understand using optical coherence tomography angiography. A systematic review</title><title>Blood reviews</title><addtitle>Blood Rev</addtitle><description>For over four decades, efforts have been underway for the evaluation of sickle cell retinopathy (SCR) in an attempt to identify peripheral high-risk vascular abnormalities based on Goldberg's classification (gold-standard) (1971). The macula is an area in the center of the retina that is responsible for high-resolution central vision and is also affected in SCR. With the development of new technologies for retinal imaging, the macula became a main focus of interest in the study of sickle cell disease (SCD). Optical coherence tomography angiography is a modern non-invasive method that allows qualitative and quantitative analysis of the retinal vascular network in the macular region. We identified 86 studies on SCD and optical coherence tomography angiography. Of those, 12 met the inclusion criteria for this systematic review. The prevalence of sickle cell maculopathy was 45.6% in the SCD population and it increased with age. We present the main vascular findings and discuss visual impairment and pathophysiology, genotypes, and peripheral high-risk vascular abnormalities. The role of the hematologist, general practitioner, and pediatrician in treatment is also reviewed.</description><subject>OCT angiography</subject><subject>Optical coherence tomography angiography</subject><subject>Sickle cell anemia</subject><subject>Sickle cell disease</subject><subject>Sickle cell maculopathy</subject><subject>Sickle cell retinopathy</subject><issn>0268-960X</issn><issn>1532-1681</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9kE1P3DAURa2KCqbAH-gCeckm6bONnaRig0b9kpC6gKrsLI_zMuMhiYPtMJp_30QzZcnKb3Hute4h5DODnAFTX7b5qg2Yc2BVDiIHYB_IgknBM6ZKdkIWwFWZVQqezsinGLcAUAlVnJIzAaXkIIsFiQ_OPrdILbYtDZhc7weTNvuv9O_GJLpD2vsdHfsaQ0ymr-kYXb-mfkjOmpZav8GAvUWafOfXwQybPTX92h3vnN7RuI8JOzMFpg9eHe4uyMfGtBEvj-85-fP92-PyZ3b_-8ev5d19ZoVUKVOK1ZIrVgnDm5LJhgtbIKgSLZdWNQW_QQtyVUPJbmzRcL4ytmy4MRVIW5TinFwfeofgX0aMSXcuzkNNj36MmrMKGAdVsAnlB9QGH2PARg_BdSbsNQM9y9ZbPcvWs2wNQk-yp9DVsX9cdVi_Rf7bnYDbA4DTyml50NG62VbtAtqka-_e6_8HbbeSLw</recordid><startdate>20190501</startdate><enddate>20190501</enddate><creator>Leitão Guerra, Ricardo Luz</creator><creator>Leitão Guerra, Cezar Luz</creator><creator>Bastos, Mariana Gouveia</creator><creator>de Oliveira, André Hasler Príncipe</creator><creator>Salles, Cristina</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20190501</creationdate><title>Sickle cell retinopathy: What we now understand using optical coherence tomography angiography. A systematic review</title><author>Leitão Guerra, Ricardo Luz ; Leitão Guerra, Cezar Luz ; Bastos, Mariana Gouveia ; de Oliveira, André Hasler Príncipe ; Salles, Cristina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-661d526193a2f815f23c7e068ec25c6f724ec05bd0814c7f22bac8f2aa905c783</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>OCT angiography</topic><topic>Optical coherence tomography angiography</topic><topic>Sickle cell anemia</topic><topic>Sickle cell disease</topic><topic>Sickle cell maculopathy</topic><topic>Sickle cell retinopathy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Leitão Guerra, Ricardo Luz</creatorcontrib><creatorcontrib>Leitão Guerra, Cezar Luz</creatorcontrib><creatorcontrib>Bastos, Mariana Gouveia</creatorcontrib><creatorcontrib>de Oliveira, André Hasler Príncipe</creatorcontrib><creatorcontrib>Salles, Cristina</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Blood reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Leitão Guerra, Ricardo Luz</au><au>Leitão Guerra, Cezar Luz</au><au>Bastos, Mariana Gouveia</au><au>de Oliveira, André Hasler Príncipe</au><au>Salles, Cristina</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sickle cell retinopathy: What we now understand using optical coherence tomography angiography. A systematic review</atitle><jtitle>Blood reviews</jtitle><addtitle>Blood Rev</addtitle><date>2019-05-01</date><risdate>2019</risdate><volume>35</volume><spage>32</spage><epage>42</epage><pages>32-42</pages><issn>0268-960X</issn><eissn>1532-1681</eissn><abstract>For over four decades, efforts have been underway for the evaluation of sickle cell retinopathy (SCR) in an attempt to identify peripheral high-risk vascular abnormalities based on Goldberg's classification (gold-standard) (1971). The macula is an area in the center of the retina that is responsible for high-resolution central vision and is also affected in SCR. With the development of new technologies for retinal imaging, the macula became a main focus of interest in the study of sickle cell disease (SCD). Optical coherence tomography angiography is a modern non-invasive method that allows qualitative and quantitative analysis of the retinal vascular network in the macular region. We identified 86 studies on SCD and optical coherence tomography angiography. Of those, 12 met the inclusion criteria for this systematic review. The prevalence of sickle cell maculopathy was 45.6% in the SCD population and it increased with age. We present the main vascular findings and discuss visual impairment and pathophysiology, genotypes, and peripheral high-risk vascular abnormalities. The role of the hematologist, general practitioner, and pediatrician in treatment is also reviewed.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>30852057</pmid><doi>10.1016/j.blre.2019.03.001</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0268-960X |
ispartof | Blood reviews, 2019-05, Vol.35, p.32-42 |
issn | 0268-960X 1532-1681 |
language | eng |
recordid | cdi_proquest_miscellaneous_2190120671 |
source | Access via ScienceDirect (Elsevier) |
subjects | OCT angiography Optical coherence tomography angiography Sickle cell anemia Sickle cell disease Sickle cell maculopathy Sickle cell retinopathy |
title | Sickle cell retinopathy: What we now understand using optical coherence tomography angiography. A systematic review |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T08%3A39%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sickle%20cell%20retinopathy:%20What%20we%20now%20understand%20using%20optical%20coherence%20tomography%20angiography.%20A%20systematic%20review&rft.jtitle=Blood%20reviews&rft.au=Leit%C3%A3o%20Guerra,%20Ricardo%20Luz&rft.date=2019-05-01&rft.volume=35&rft.spage=32&rft.epage=42&rft.pages=32-42&rft.issn=0268-960X&rft.eissn=1532-1681&rft_id=info:doi/10.1016/j.blre.2019.03.001&rft_dat=%3Cproquest_cross%3E2190120671%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2190120671&rft_id=info:pmid/30852057&rft_els_id=S0268960X1830119X&rfr_iscdi=true |